{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Arcutis Biotherapeutics, Inc."},"Symbol":{"label":"Symbol","value":"ARQT"},"Address":{"label":"Address","value":"3027 TOWNSGATE ROAD SUITE 300, WESTLAKE VILLAGE, California, 91361, United States"},"Phone":{"label":"Phone","value":"+1 805 418-5006"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population."},"CompanyUrl":{"label":"Company Url","value":"https://www.arcutis.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Berk","title":"Vice President-Clinical Development"},{"name":"David W. Osborne","title":"Chief Technical Officer"},{"name":"Patricia A. Turney","title":"Senior Vice President-Operations"},{"name":"Patrick Burnett","title":"Chief Medical Officer"},{"name":"Todd Franklin Watanabe","title":"President, Chief Executive Officer &amp; Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}